RNA Based Therapeutics Market Overview
RNA Based Therapeutics Market Report, published by Allied Market Research, forecasts that the global market is expected to garner $1.2 billion by 2020, registering a CAGR of 28.4% during the period 2014-2020. Due to its ability to render targeted solutions for chronic diseases such as cancer, AIDS, rare genetic disorders, and certain cardiovascular conditions, RNA based therapeutics is expected to significantly impact the global pharmaceutical industry. Download the Sample Report @ http://bit.ly/2KTTCdM The large scale funding from public and private sector, growing interest of pharmaceuticals and biotech giants for developing novel delivery technology, and anticipated saving in healthcare expenditure are propelling the growth of RNA therapeutics market. Moreover, the platform technologies such as RNAi and antisense have enabled researchers to accelerate their research activities by defining gene sequences for chronic diseases. Companies have widened the research focus...